Market Closed -
Borsa Istanbul
11:09:01 2024-05-21 am EDT
|
5-day change
|
1st Jan Change
|
522.5
TRY
|
+2.75%
|
|
+2.45%
|
+120.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
226.7
|
557.7
|
2,519
|
2,250
|
3,480
|
38,729
|
Enterprise Value (EV)
1 |
-250.7
|
-98.61
|
1,716
|
1,383
|
1,582
|
35,469
|
P/E ratio
|
7.98
x
|
11.1
x
|
42.8
x
|
32.9
x
|
19.4
x
|
42.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.59
x
|
1
x
|
3.9
x
|
2.46
x
|
2.1
x
|
8.19
x
|
EV / Revenue
|
-0.66
x
|
-0.18
x
|
2.66
x
|
1.51
x
|
0.96
x
|
7.5
x
|
EV / EBITDA
|
-17
x
|
-1.53
x
|
29
x
|
-134
x
|
10.5
x
|
53.9
x
|
EV / FCF
|
-3
x
|
-0.58
x
|
10.8
x
|
19.9
x
|
1.29
x
|
19.3
x
|
FCF Yield
|
-33.4%
|
-172%
|
9.26%
|
5.03%
|
77.5%
|
5.18%
|
Price to Book
|
1.07
x
|
2.13
x
|
7.46
x
|
5.12
x
|
3.91
x
|
19.2
x
|
Nbr of stocks (in thousands)
|
163,070
|
163,070
|
163,070
|
163,070
|
163,070
|
163,070
|
Reference price
2 |
1.390
|
3.420
|
15.45
|
13.80
|
21.34
|
237.5
|
Announcement Date
|
2/28/19
|
2/28/20
|
2/25/21
|
2/22/22
|
2/28/23
|
2/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
381.3
|
558
|
645.5
|
914
|
1,653
|
4,726
|
EBITDA
1 |
14.73
|
64.28
|
59.26
|
-10.33
|
150
|
658
|
EBIT
1 |
9.896
|
57.89
|
51.72
|
-20.64
|
133
|
607.5
|
Operating Margin
|
2.6%
|
10.37%
|
8.01%
|
-2.26%
|
8.05%
|
12.85%
|
Earnings before Tax (EBT)
1 |
37.02
|
64.4
|
74.63
|
90.46
|
219
|
1,037
|
Net income
1 |
28.39
|
50.08
|
58.92
|
68.32
|
179.7
|
901.9
|
Net margin
|
7.45%
|
8.97%
|
9.13%
|
7.47%
|
10.87%
|
19.08%
|
EPS
2 |
0.1741
|
0.3071
|
0.3613
|
0.4189
|
1.102
|
5.531
|
Free Cash Flow
1 |
83.64
|
169.5
|
158.8
|
69.54
|
1,225
|
1,838
|
FCF margin
|
21.94%
|
30.37%
|
24.61%
|
7.61%
|
74.12%
|
38.9%
|
FCF Conversion (EBITDA)
|
567.94%
|
263.64%
|
268%
|
-
|
817%
|
279.39%
|
FCF Conversion (Net income)
|
294.59%
|
338.38%
|
269.55%
|
101.8%
|
681.8%
|
203.82%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/28/19
|
2/28/20
|
2/25/21
|
2/22/22
|
2/28/23
|
2/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
477
|
656
|
803
|
867
|
1,898
|
3,260
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
83.6
|
169
|
159
|
69.5
|
1,225
|
1,838
|
ROE (net income / shareholders' equity)
|
14.3%
|
21.1%
|
19.6%
|
17.6%
|
27%
|
62.1%
|
ROA (Net income/ Total Assets)
|
0.74%
|
3.29%
|
2.11%
|
-0.63%
|
2.15%
|
4.66%
|
Assets
1 |
3,815
|
1,525
|
2,795
|
-10,782
|
8,347
|
19,370
|
Book Value Per Share
2 |
1.300
|
1.610
|
2.070
|
2.700
|
5.460
|
12.40
|
Cash Flow per Share
2 |
2.930
|
4.050
|
4.960
|
5.360
|
11.70
|
20.00
|
Capex
1 |
3.39
|
1.83
|
10.2
|
1.01
|
20.2
|
82.9
|
Capex / Sales
|
0.89%
|
0.33%
|
1.57%
|
0.11%
|
1.22%
|
1.75%
|
Announcement Date
|
2/28/19
|
2/28/20
|
2/25/21
|
2/22/22
|
2/28/23
|
2/21/24
|
|
1st Jan change
|
Capi.
|
---|
| +120.00% | 2.57B | | +14.99% | 80.65B | | +9.77% | 51.83B | | +6.17% | 49.83B | | +22.95% | 47.95B | | +13.62% | 42.26B | | +22.85% | 40.19B | | +1.73% | 30.05B | | -1.92% | 29.32B | | -10.10% | 28.03B |
Other Life & Health Insurance
|